project id: TCGA-MESO; case submitter id: TCGA-MQ-A6BL; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.08; rna integrity number: 7.2; age at index: 78; days to birth: -28590; days to death: 333; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1929; year of death: 2007; age at diagnosis: 28590; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9053/3; primary diagnosis: Mesothelioma, biphasic, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 2287; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-MQ-A6BL-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 15.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;